Cargando…

Pathophysiology and Classification of Cardiovascular Diseases Caused by Atherosclerosis

Detalles Bibliográficos
Autor principal:	Reiner, Željko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2003
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169134/ https://www.ncbi.nlm.nih.gov/pubmed/30302072

Ejemplares similares

Pathophysiology of Atherosclerosis
por: Jebari-Benslaiman, Shifa, et al.
Publicado: (2022)

Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease
por: Frąk, Weronika, et al.
Publicado: (2022)

Metabolic-Dysfunction-Associated Steatotic Liver Disease—Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

The Role of Lipids in the Development of Atherosclerosis and Coronary Heart Disease: Guidelines for Diagnosis and Treatment
por: Blaton, Victor
Publicado: (2003)

Pathophysiology and Classification of Neurodegenerative Diseases
por: Relja, Maja
Publicado: (2004)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
por: Adorni, Maria Pia, et al.
Publicado: (2021)

Genetics of Cardiovascular Disease
por: Stavljenic-Rukavina, Ana
Publicado: (2003)

Role of Endoplasmic Reticulum and Oxidative Stress Parameters in the Pathophysiology of Disease-Related Malnutrition in Leukocytes of an Outpatient Population
por: Bañuls, Celia, et al.
Publicado: (2019)

Cardiovascular health and subclinical atherosclerosis in second generation South Asian Americans: The MASALA study
por: Shah, Nilay S., et al.
Publicado: (2021)

(18)F–THK–5351, Fluorodeoxyglucose, and Florbetaben PET Images in Atypical Alzheimer’s Disease: A Pictorial Insight into Disease Pathophysiology
por: Park, Sohee, et al.
Publicado: (2021)

Potential role of Lu/BCAM in HIV-related atherosclerosis
por: Motswaledi, Modisa S., et al.
Publicado: (2019)

Strategy of Prevention of Cardiovascular Disease
por: Kovács, Gábor L., et al.
Publicado: (2003)

Diabetes Mellitus and Cardiovascular Disease
por: Aganovic, Izet
Publicado: (2003)

Rational Diagnosis of Cardiovascular Disease
por: Müller, Mathias M., et al.
Publicado: (2003)

Atherothrombosis: Pathogenesis of Cardiovascular Disease
por: Mojca, Stegnar
Publicado: (2003)

Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

1. Pathophysiology and Classification of Kidney Diseases
por: Matovinović, Mirjana Sabljar
Publicado: (2009)

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
por: Borén, Jan, et al.
Publicado: (2020)

Pathophysiology, pharmacotherapy, cardiovascular disease
por: Sharma, Kamal H.
Publicado: (2015)

Pathophysiology and pharmacology of cardiovascular disease
por: Selvaraj, Raja J.
Publicado: (2016)

The Role of Pharmacogenetics in Management of Cardiovascular Disease
por: Topic, Elizabeta
Publicado: (2003)

Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia
por: Gaggini, Melania, et al.
Publicado: (2022)

Assessing the Accuracy of International Classification of Diseases (ICD) Coding for Delirium
por: Chuen, Victoria L, et al.
Publicado: (2022)

A Drop in Hemoglobin as an Association with Pegylated Interferon Retinopathy: A Novel Pathophysiology
por: Berkenstock, Meghan, et al.
Publicado: (2020)

Psychological and psychopathological sequelae in cardiovascular acute disease
por: Caponnetto, Pasquale
Publicado: (2018)

Dysautonomia in Children with Post-Acute Sequelae of Coronavirus 2019 Disease and/or Vaccination
por: Buchhorn, Reiner
Publicado: (2022)

Does hypoglycemia cause cardiovascular events?
por: Chopra, Sandeep, et al.
Publicado: (2012)

Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis
por: Moss, Mary E., et al.
Publicado: (2015)

Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis
por: Bobryshev, Yuri V., et al.
Publicado: (2016)

Pathophysiologic Mechanisms of Tobacco Smoke Producing Atherosclerosis
por: Klein, Lloyd W.
Publicado: (2022)

Immunity, atherosclerosis and cardiovascular disease
por: Frostegård, Johan
Publicado: (2013)

Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017)

Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study
por: Drozd, Michael, et al.
Publicado: (2021)

IL-33 reduces the development of atherosclerosis
por: Miller, Ashley M., et al.
Publicado: (2008)

Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy
por: Bolignano, Davide, et al.
Publicado: (2022)

Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide
por: Verma, Subodh, et al.
Publicado: (2021)

Unusual pattern of herpetic optic neuropathy: a case report and literature review of the pathophysiology of herpetic uveitis
por: Helal, Rehab Sabry, et al.
Publicado: (2023)

Personalization and Learning Outcome in a Nursing Pathophysiology and Pharmacology Course: Canvas(©) Mastery Adoption Pilot Study
por: Hinkle, Julie F.
Publicado: (2023)

Willis-Ekbom disease is not associated with poor cardiovascular health in adults
por: Dredla, Brynn K., et al.
Publicado: (2015)

Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases
por: Delbaere, Quentin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aomj9et6kang7bmhegos1tt10n